ProfileGDS5678 / 1448279_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 98% 99% 99% 98% 98% 98% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.847699
GSM967853U87-EV human glioblastoma xenograft - Control 211.004199
GSM967854U87-EV human glioblastoma xenograft - Control 310.848399
GSM967855U87-EV human glioblastoma xenograft - Control 410.844398
GSM967856U87-EV human glioblastoma xenograft - Control 511.107599
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.594699
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.191198
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.590598
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.537798
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 111.015899
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.079599
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.016299
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 411.20199
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 511.150299